list of fda approved glp-1 receptor agonists What to know about the new era drugs GLP-1 Agonists - Endocrinology Advisor

the challenges of GLP-1 agonist use

There are specific concerns about tirzepatide during breastfeeding and pregnancy that warrant careful medical supervision

Davies said several GLP-1/glucagon dual agonists have moved on to phase 2 or phase 3 trials, including survodutide (Boehringer Ingelheim), efinopegdutide (Hanmi Pharmaceutical), mazdutide (Eli Lilly and Innovent) and pemvidutide (Altimmune)

Wang N, et al

Semaglutide, the active ingredient in Novo Nordisks Ozempic and Wegovy, has been in short supply since March 2022 amid the drugs surging popularity

Further reading A guide to prescription weight loss treatments Wegovy interactions: what you need to know Reviewed by Dr